PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma

NCT02615730 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Adenocarcinoma

Interventions

DRUG: GSK2636771
DRUG: Paclitaxel

Sponsor

Yonsei University